Skip to main content

Search

28 result(s) for 'author#John A. Spertus' within BMC

Page 1 of 2

Sort by: Relevance | Date

  1. The year 2009 has been a busy one for the SCMR. With health care reform in the headlines, SCMR is committed to expanding the use of CMR in clinical practice and research. Progress is being made quickly as the ...

    Authors: Christopher M Kramer
    Citation: Journal of Cardiovascular Magnetic Resonance 2009 11:32
    Content type: Editorial Published on:

  3. The editors of Health and Quality of Life Outcomes would like to thank all our reviewers who have contributed to the journal in Volume 13 (2015).

    Authors: Holger Schunemann and Feng Xie
    Citation: Health and Quality of Life Outcomes 2016 14:29
    Content type: Reviewer acknowledgement Published on:

  4. Diabetes is an important predictor of mortality patients with ACS. However, little is known about the association between diabetes and health status after ACS. The objective of this study was to examine the as...

    Authors: Pamela N Peterson, John A Spertus, David J Magid, Fredrick A Masoudi, Kimberly Reid, Richard F Hamman and John S Rumsfeld
    Citation: BMC Cardiovascular Disorders 2006 6:41
    Content type: Research article Published on:

  5. Coronary artery disease (CAD) remains a severe socio-economic burden in the Western world. Coronary obstruction and subsequent myocardial ischemia result in the progressive replacement of contractile myocardiu...

    Authors: Felix Nägele, Leo Pölzl, Michael Graber, Jakob Hirsch, Agnes Mayr, Mathias Pamminger, Felix Troger, Markus Theurl, Michael Schreinlechner, Nikolay Sappler, Christian Dorfmüller, Martina Mitrovic, Hanno Ulmer, Michael Grimm, Can Gollmann-Tepeköylü and Johannes Holfeld
    Citation: Trials 2022 23:988
    Content type: Update Published on:

    The Study protocol to this article has been published in Trials 2020 21:447

  6. Unstable angina (UA) patients have lower mortality and reinfarction risks than ST-elevation (STEMI) or non-ST elevation myocardial infarction (NSTEMI) patients and, accordingly, receive less aggressive treatme...

    Authors: Thomas M Maddox, Kimberly J Reid, John S Rumsfeld and John A Spertus
    Citation: BMC Cardiovascular Disorders 2007 7:28
    Content type: Research article Published on:

  7. Data-sharing policies in randomized clinical trials (RCTs) should have an evaluation component. The main objective of this case–control study was to assess the impact of published re-uses of RCT data in terms ...

    Authors: N. Anthony, C. Pellen, C. Ohmann, D. Moher and F. Naudet
    Citation: BMC Medical Research Methodology 2021 21:119
    Content type: Research Published on:

  12. Achieving 'personalized medicine' requires enrolling representative cohorts into genetic studies, but patient self-selection may introduce bias. We sought to identify characteristics associated with genetic co...

    Authors: David E Lanfear, Philip G Jones, Sharon Cresci, Fengming Tang, Saif S Rathore and John A Spertus
    Citation: Genome Medicine 2011 3:39
    Content type: Research Published on:

  13. Cardiac resynchronisation therapy (CRT) can profoundly improve outcome in selected patients with heart failure; however, response is difficult to predict and can be absent in up to one in three patients. There...

    Authors: Sitara GKhan, Dimitris Klettas, Stam Kapetanakis and Mark J. Monaghan
    Citation: Echo Research & Practice 2016 3:301009
    Content type: Review Published on:

  14. Genome-wide association studies (GWAS) have identified new candidate genes for the occurrence of acute coronary syndrome (ACS), but possible effects of such genes on survival following ACS have yet to be inves...

    Authors: Thomas M Morgan, John A House, Sharon Cresci, Philip Jones, Hooman Allayee, Stanley L Hazen, Yesha Patel, Riyaz S Patel, Danny J Eapen, Salina P Waddy, Arshed A Quyyumi, Marcus E Kleber, Winfried März, Bernhard R Winkelmann, Bernhard O Boehm, Harlan M Krumholz…
    Citation: BMC Medical Genetics 2011 12:127
    Content type: Research article Published on:

  15. There has been limited success in achieving integration of patient-reported outcomes (PROs) in clinical trials. We describe how stakeholders envision a solution to this challenge.

    Authors: Theresa M. Coles, Adrian F. Hernandez, Bryce B. Reeve, Karon Cook, Michael C. Edwards, Marc Boutin, Elizabeth Bush, Arnold Degboe, Lothar Roessig, Amy Rudolph, Pauline McNulty, Nikunj Patel, Trish Kay-Mugford, Margaret Vernon, Michael Woloschak, Gustavo Buchele…
    Citation: Health and Quality of Life Outcomes 2021 19:164
    Content type: Commentary Published on:

  16. We assessed the degree to which differences in guideline-based medical therapy for acute myocardial infarction (AMI) contribute to the higher mortality associated with kidney disease.

    Authors: Pamela N Peterson, Amrut V Ambardekar, Philip G Jones, Harlan M Krumholz, Erik Schelbert, John A Spertus, John S Rumsfeld and Frederick A Masoudi
    Citation: BMC Cardiovascular Disorders 2009 9:29
    Content type: Research article Published on:

  17. Previous investigations suggest an important role of social support in the outcomes of patients treated for ischemic heart disease. The ENRICHD Social Support Instrument (ESSI) is a 7-item self-report survey t...

    Authors: Joseph Vaglio Jr, Mark Conard, Walker S Poston, James O'Keefe, C Keith Haddock, John House and John A Spertus
    Citation: Health and Quality of Life Outcomes 2004 2:24
    Content type: Research Published on:

  18. In the setting of coronary angiography, generic consent forms permit highly variable communication between patients and physicians. Even with the existence of multiple risk models, clinicians have been unable ...

    Authors: Carole Decker, Suzanne V Arnold, Olawale Olabiyi, Homaa Ahmad, Elizabeth Gialde, Jamie Luark, Lisa Riggs, Terry DeJaynes, Gabriel E Soto and John A Spertus
    Citation: Implementation Science 2008 3:58
    Content type: Research article Published on:

  19. Responsiveness, or sensitivity to clinical change, is an important consideration in selection of a health-related quality of life (HRQL) measure for trials or clinical applications. Many approaches can be used...

    Authors: Dean T Eurich, Jeffrey A Johnson, Kimberly J Reid and John A Spertus
    Citation: Health and Quality of Life Outcomes 2006 4:89
    Content type: Research Published on:

  20. Patient-reported outcome (PRO) measures can be used to support label claims if they adhere to US Food & Drug Administration guidance. The process of developing a new PRO measure is expensive and time-consuming...

    Authors: Ingela Wiklund, Milena Anatchkova, Hafiz Oko-Osi, Robyn von Maltzahn, Dina Chau, Fady I. Malik, Donald L. Patrick, John Spertus and John R. Teerlink
    Citation: Health and Quality of Life Outcomes 2016 14:131
    Content type: Research Published on: